Top

International Journal of Hematology

Published in:

01-04-2004 | Case Report

Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect

Authors: Song-He Chen, Xin Li, Xiao-Jun Huang

Published in: International Journal of Hematology | Issue 2/2004

Title: Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect
Authors: Song-He Chen
Xin Li
Xiao-Jun Huang
Publication date: 01-04-2004
Publisher: Springer-Verlag
Published in: International Journal of Hematology / Issue 2/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI: https://doi.org/10.1532/IJH97.A10227

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2004

The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors

Erratum to: Clinical evaluation of a recombinant factor VIII preparation (kogenate) in previously untreated patients with hemophilia A

Tuberculosis in hematopoletk stem cell transplant recipients in Korea

Clinical Response of Antilymphocyte Globulin-Based Treatment in Patients in Taiwan with Aplastic Anemia: Positive Hepatitis C Antibody May Represent a Response Predictor

Bone marrow hypoplasia complicating tacrolimus (FK506) therapy

Successful treatment of µ-heavy chain disease with fludarabine monophosphate: A case report

Keynote webinar | Spotlight on antibody–drug conjugates in cancer